DrugBank Open Data2026Reference DatabaseEN
DrugBank: Insulin Glargine - Pharmacological Profile
Zusammenfassung
DRUGBANK PHARMACOLOGICAL PROFILE: Insulin Glargine
Drug Class: Long-acting basal insulin analogue
Category: Endocrine
=== MECHANISM OF ACTION ===
Recombinant insulin analogue with modified amino acid sequence (asparagine to glycine at A21, two arginines at B chain). Forms microprecipitates at physiological pH after injection, providing slow, peakless, 24-hour release.
=== INDICATIONS ===
- Type 1 diabetes mellitus
- Type 2 diabetes mellitus (when oral agents insufficient)
=== CONTRAINDICATIO
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
DrugBank Open Data2026
DrugBank: Liraglutide - Pharmacological Profile
DrugBank Open Data2026
DrugBank: Metformin - Pharmacological Profile
DrugBank Open Data2026
DrugBank: Sitagliptin - Pharmacological Profile
DrugBank Open Data2026
DrugBank: Empagliflozin - Pharmacological Profile
Diabetes Canada2018
Diabetes Canada Chapter 12: Glycemic Management in Adults with Type 1 Diabetes
Cochrane2021
Cochrane Review: (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus
DrugBank Open Data2026
DrugBank: Levothyroxine - Pharmacological Profile
Diabetes Canada2018